Postprandial Glucose RegulationIMERACAROBGLUCNCT06906965
Effect of the Imera Cultivar Carob in Postprandial Glycemia
A study testing Carob beverage and Sucrose beverage in people with Postprandial Glucose Regulation, run by Harokopio University at 1 site in Greece.
Trial summary
An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response Read more about this study
- Who is it for?
- Ages 18 years and older, men onlyHealthy volunteers can take part
- Conditions the study is for
- Postprandial Glucose Regulation
- What is being tested?
- Carob beverage and Sucrose beverage
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 15 participants
- Where
- 1 siteGreece
- Study dates
- 31 Jan 2024to 30 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Men only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- healthy male adults of normal body fat mass
Who cannot join
- obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.
Trial locations and contacts
1 site in 1 country.
Greece1 site
Department of Nutrition and Dietetics, HarokopioUniversity of Athens
Kallithea, Attica, 17676
About this study
Official title: Impact of the Imera Carob Cultivar in Postprandial Glycemia
An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response
Read the detailed description
This is an acute randomized crossover study on the effect of an Imera cultivar carob beverage on postprandial glycemic response in healthy individuals as opposed to sucrose-based beverage containing sugar in alike concentration
- Conditions
- Postprandial Glucose Regulation
- Being tested
- Carob beverage, Sucrose beverage
- Keywords
- postprandial glucose, glucose regulation, carob, carob powder, postprandial insulin
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Carob beverageOther
The participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water
Sucrose beverageOther
The participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage
| Study group | Role | What they receive |
|---|---|---|
| Carob beverage | Experimental | The participants consumed a carob beverage prepared with 30 g of Imera cultivar carob powder dissolved in water Receives: Other: Carob beverage |
| Sucrose beverage | Active comparator | The participants consumed a sucrose beverage made containing 14 g of sugar, matched to the sugar concentration of the experimental beverage Receives: Other: Sucrose beverage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postprandial glucose
Changes in glucose levels after the consumption of the beverage
Measured: 3 hours
Secondary outcomes (1)
Postprandial insulin
Changes in insulin levels after consuming the beverage
Measured: 3 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Apr 2025
- Study start31 Jan 2024
- Primary completion31 May 2024
- Study completion30 Sep 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Postprandial Glucose RegulationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 15 participants (actual)
Sponsor and investigators
- Lead sponsor
- Harokopio University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Andriana C. Kaliora, Harokopio University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06906965
- Sponsor's protocol ID
- CAROB_GLUCOSE_147
- Other IDs
- 016713
- Acronym
- IMERACAROBGLUC
- Status last verified
- Mar 2025
- First submitted
- 26 Mar 2025
- Last updated
- 6 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of the Imera Carob Cultivar in Postprandial Glycemia
- ClinicalTrials.gov ID
- NCT06906965
- Acronym / sponsor ID
- IMERACAROBGLUC / CAROB_GLUCOSE_147
- Conditions
- Postprandial Glucose Regulation
- Keywords
- postprandial glucose, glucose regulation, carob, carob powder, postprandial insulin
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 15 participants (actual)
- Lead sponsor
- Harokopio UniversityUniversity, hospital or other
- Study start
- 31 Jan 2024 (actual)
- Primary completion
- 31 May 2024 (actual)
- Study completion
- 30 Sep 2024 (actual)
- First posted
- 2 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An acute randomized crossover study on the effect of a carob beverage on postprandial glycemic response
Detailed description
This is an acute randomized crossover study on the effect of an Imera cultivar carob beverage on postprandial glycemic response in healthy individuals as opposed to sucrose-based beverage containing sugar in alike concentration
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Carob beverage | Experimental | Other: Carob beverageThe participants consumed a carob beverage prepared with 30 g of Imera cultivar carob powder dissolved in water |
| Sucrose beverage | Active comparator | Other: Sucrose beverageThe participants consumed a sucrose beverage made containing 14 g of sugar, matched to the sugar concentration of the experimental beverage |
Who may qualify
- Ages
- 18 years and older
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- healthy male adults of normal body fat mass
Key exclusion criteria (1 listed)
- obesity (according to body fat mass), type 1 Diabetes, hypertension and other cardiovascular diseases, thyroid disorder, liver, kidney, gastrointestinal disease, mental illness, use of nutraceutical supplements or natural products for weight loss and the background of dietitian/nutritionist.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Carob beverageThe participants consumed a carob beverage made with 30gr of Imera carob cultivar powder in water | Other | Carob beverage |
| Sucrose beverageThe participants consumed a sucrose beverage made with 14gr of sugar in alike concentration with sugars in the experimental beverage | Other | Sucrose beverage |
Primary outcome
Postprandial glucose
Time frame: 3 hours
Changes in glucose levels after the consumption of the beverage
1 secondary outcome
Postprandial insulin
Time frame: 3 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Apr 2025.
- Individual participant dataSharing planned: No
Related trials for Postprandial Glucose Regulation
Recruiting
Effects of Wheat Flour Milling Method on Glycemic Response and Gastrointestinal Symptoms
Gastrointestinal Irritation, Nutrition, Healthy
Not yet recruiting
The Impact of a Daily Dietary Supplement on Glycemic Control in Individuals With Overweight or Obesity
Glycemic Control, Appetite Regulation
Recruiting
Effect of SugarLock® Peanut Skin Extract on Postprandial Blood Glucose Control
Blood Sugar (Glucose) Control, Postprandial Glucose
Recruiting
Effects of GLP-1 Formula on GLP-1 and Glucose Regulation
Overweight
Recruiting
POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS
Postural Orthostatic Tachycardia Syndrome (POTS), Healthy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Carob beverage and Sucrose beverage in people with Postprandial Glucose Regulation, run by Harokopio University at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postprandial glucose (time frame: 3 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2025.